These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

71 related articles for article (PubMed ID: 23991971)

  • 1. Prediction of promiscuous epitopes in the e6 protein of three high risk human papilloma viruses: a computational approach.
    Subramanian N; Chinnappan S
    Asian Pac J Cancer Prev; 2013; 14(7):4167-75. PubMed ID: 23991971
    [TBL] [Abstract][Full Text] [Related]  

  • 2. HPV-16 E6 and E7 protein T cell epitopes prediction analysis based on distributions of HLA-A loci across populations: an in silico approach.
    Yao Y; Huang W; Yang X; Sun W; Liu X; Cun W; Ma Y
    Vaccine; 2013 Apr; 31(18):2289-94. PubMed ID: 23499609
    [TBL] [Abstract][Full Text] [Related]  

  • 3. HLA class I binding promiscuity of the CD8 T-cell epitopes of human papillomavirus type 16 E6 protein.
    Nakagawa M; Kim KH; Gillam TM; Moscicki AB
    J Virol; 2007 Feb; 81(3):1412-23. PubMed ID: 17108051
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Identification of epitopes in Indian human papilloma virus 16 E6: a bioinformatics approach.
    Singh AK; Rath SK; Misra K
    J Virol Methods; 2011 Oct; 177(1):26-30. PubMed ID: 21699918
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Identification of the impact on T- and B- cell epitopes of human papillomavirus type-16 E6 and E7 variant in Southwest China.
    Chenzhang Y; Wen Q; Ding X; Cao M; Chen Z; Mu X; Wang T
    Immunol Lett; 2017 Jan; 181():26-30. PubMed ID: 27693214
    [TBL] [Abstract][Full Text] [Related]  

  • 6. CD4+ T cell immunity against the human papillomavirus-18 E6 transforming protein in healthy donors: identification of promiscuous naturally processed epitopes.
    Facchinetti V; Seresini S; Longhi R; Garavaglia C; Casorati G; Protti MP
    Eur J Immunol; 2005 Mar; 35(3):806-15. PubMed ID: 15719368
    [TBL] [Abstract][Full Text] [Related]  

  • 7. T-helper epitopes identified within the E6 transforming protein of cervical cancer-associated human papillomavirus type 16.
    Azoury-Ziadeh R; Herd K; Fernando GJ; Frazer IH; Tindle RW
    Viral Immunol; 1999; 12(4):297-312. PubMed ID: 10630789
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Designing of Epitope-Focused Vaccine by Targeting E6 and E7 Conserved Protein Sequences: An Immuno-Informatics Approach in Human Papillomavirus 58 Isolates.
    Sabah SN; Gazi MA; Sthity RA; Husain AB; Quyyum SA; Rahman M; Islam MR
    Interdiscip Sci; 2018 Jun; 10(2):251-260. PubMed ID: 27640170
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Different methods of identifying new antigenic epitopes of human papillomavirus type 16 E6 and E7 proteins.
    Nakagawa M; Kim KH; Moscicki AB
    Clin Diagn Lab Immunol; 2004 Sep; 11(5):889-96. PubMed ID: 15358648
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prediction of epitopes and structural properties of Iranian HPV-16 E6 by bioinformatics methods.
    Mohabatkar H
    Asian Pac J Cancer Prev; 2007; 8(4):602-6. PubMed ID: 18260737
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Human CTL epitopes encoded by human papillomavirus type 16 E6 and E7 identified through in vivo and in vitro immunogenicity studies of HLA-A*0201-binding peptides.
    Ressing ME; Sette A; Brandt RM; Ruppert J; Wentworth PA; Hartman M; Oseroff C; Grey HM; Melief CJ; Kast WM
    J Immunol; 1995 Jun; 154(11):5934-43. PubMed ID: 7538538
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Identification of an HLA-A24-restricted cytotoxic T lymphocyte epitope from human papillomavirus type-16 E6: the combined effects of bortezomib and interferon-gamma on the presentation of a cryptic epitope.
    Morishima S; Akatsuka Y; Nawa A; Kondo E; Kiyono T; Torikai H; Nakanishi T; Ito Y; Tsujimura K; Iwata K; Ito K; Kodera Y; Morishima Y; Kuzushima K; Takahashi T
    Int J Cancer; 2007 Feb; 120(3):594-604. PubMed ID: 17096336
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Identification of human papillomavirus-16 E6 variation in cervical cancer and their impact on T and B cell epitopes.
    Kumar A; Hussain S; Yadav IS; Gissmann L; Natarajan K; Das BC; Bharadwaj M
    J Virol Methods; 2015 Jun; 218():51-8. PubMed ID: 25800725
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Design, Immune Responses and Anti-Tumor Potential of an HPV16 E6E7 Multi-Epitope Vaccine.
    de Oliveira LM; Morale MG; Chaves AA; Cavalher AM; Lopes AS; Diniz Mde O; Schanoski AS; de Melo RL; Ferreira LC; de Oliveira ML; Demasi M; Ho PL
    PLoS One; 2015; 10(9):e0138686. PubMed ID: 26390407
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Motif analysis of HLA class II molecules that determine the HPV associated risk of cervical carcinogenesis.
    Odunsi K; Ganesan T
    Int J Mol Med; 2001 Oct; 8(4):405-12. PubMed ID: 11562779
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Broad Cross-Protection Is Induced in Preclinical Models by a Human Papillomavirus Vaccine Composed of L1/L2 Chimeric Virus-Like Particles.
    Boxus M; Fochesato M; Miseur A; Mertens E; Dendouga N; Brendle S; Balogh KK; Christensen ND; Giannini SL
    J Virol; 2016 Jul; 90(14):6314-25. PubMed ID: 27147749
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Development of a DNA vaccine targeting human papillomavirus type 16 oncoprotein E6.
    Peng S; Ji H; Trimble C; He L; Tsai YC; Yeatermeyer J; Boyd DA; Hung CF; Wu TC
    J Virol; 2004 Aug; 78(16):8468-76. PubMed ID: 15280455
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Recognition of a cervical cancer derived tumor cell line by a human papillomavirus type 16 E6 52-61-specific CD8 T cell clone.
    Kim KH; Dishongh R; Santin AD; Cannon MJ; Bellone S; Nakagawa M
    Cancer Immun; 2006 Jun; 6():9. PubMed ID: 16808432
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Identification in humans of HPV-16 E6 and E7 protein epitopes recognized by cytolytic T lymphocytes in association with HLA-B18 and determination of the HLA-B18-specific binding motif.
    Bourgault Villada I; Bénéton N; Bony C; Connan F; Monsonego J; Bianchi A; Saiag P; Lévy JP; Guillet JG; Choppin J
    Eur J Immunol; 2000 Aug; 30(8):2281-9. PubMed ID: 10940919
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Patterns of CD8 T-cell epitopes within the human papillomavirus type 16 (HPV 16) E6 protein among young women whose HPV 16 infection has become undetectable.
    Nakagawa M; Kim KH; Moscicki AB
    Clin Diagn Lab Immunol; 2005 Aug; 12(8):1003-5. PubMed ID: 16085919
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.